2022 annual financial data

Trevi Therapeutics 2022 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -29,907,000 USD and net income was -29,152,000 USD.
Operating cash flow was -28,175,000 USD.

Get free Trevi Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-29,907,000 USD
Net income
-29,152,000 USD
Operating cash flow
-28,175,000 USD